Diabetic nephropathy in type 2 diabetes – from pathological mechanisms to clinical occupational medicine practice

1. Mota M, Popa SG, Mota E, Mitrea A, Catrinoiu D, Cheta DM, Guja C, Hancu N, Ionescu-Tirgoviste C, Lichiardopol R, Mihai BM, Popa AR, Zetu C, Bala CG, Roman G, Serafinceanu C, Serban V, Timar R, Veresiu IA, Vlad AR. Prevalence of diabetes mellitus and prediabetes in the adult Romanian population: PREDATORR study. J Diabetes. 2016;8:336-44.10.1111/1753-0407.12297Search in Google Scholar

2. Sorrentino FS, Matteini S, Bonifazzi C, Sebastiani A, Parmeggiani F. Diabetic retinopathy and endothelin system: microangiopathy versus endothelial dysfunction. Eye. 2018; 32:1157–63.10.1038/s41433-018-0032-4Open DOISearch in Google Scholar

3.Vinod PB. Pathophysiology of diabetic nephropathy. Clinical Queries: Nephrology. 2012;1:121-6.10.1016/S2211-9477(12)70005-5Search in Google Scholar

4. Martínez-Castelao A, Navarro-González JF, Górriz JL, de Alvaro F. The Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent Years. J Clin Med. 2015;4:1207–16.10.3390/jcm4061207448499526239554Search in Google Scholar

5. Piccoli GB, Grassi G, Cabiddu G, Nazha M, Roggero S, Capizzi I, De Pascale A, Priola AM, Di Vico C, Maxia S, Loi V, Asunis AM, Pani A, Veltri A. Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease. Rev Diabet Stud. 2015;12:87–109.10.1900/RDS.2015.12.87539798526676663Search in Google Scholar

6. Pizzorno J. Is the Diabetes Epidemic Primarily Due to Toxins?. Integr Med (Encinitas). 2016;15:8–17.Search in Google Scholar

7. Edwards J, Ackerman C. A Review of Diabetes Mellitus and Exposure to the Environmental Toxicant Cadmium with an Emphasis on Likely Mechanisms of Action. Curr Diabetes Rev. 2016;12:252–8.10.2174/1573399811666150812142922500294026264451Open DOISearch in Google Scholar

8. Orr SE, Bridges CC. Chronic Kidney Disease and Exposure to Nephrotoxic Metals. Int J Mol Sci. 2017;18:1039.2849832010.3390/ijms18051039545495128498320Search in Google Scholar

9. Ahamed M, Siddiqui MK.Low level lead exposure and oxidative stress: current opinions. Clin Chim Acta. 2007;383:57-64.10.1016/j.cca.2007.04.02417573057Search in Google Scholar

10. Burckhardt BC, Drinkuth B, Menzel C, Konig A, Steffgen J, Wright SH, Burckhardt G. The renal Na(+)-dependent dicarboxylate transporter, NaDC-3, translocates dimethyl- and disulfhydryl-compounds and contributes to renal heavy metal detoxification. J. Am. Soc. Nephrol. 2002;13:2628–38.Search in Google Scholar

11. Barbier O, Jacquillet G, Tauc M, Cougnon M, Poujeol P. Effect of heavy metals on, and handling by, the Kidney. Nephron Physiol 2005;99:105-10.10.1159/00008398115722646Search in Google Scholar

12. Jacob S, Héry M, Protois JC, Rossert J, Stengel B. New insight into solvent-related end-stage renal disease: occupations, products and types of solvents at risk. Occup Environ Med. 2007;64:843–8.10.1136/oem.2007.032482209535217567724Search in Google Scholar

13. Prozialeck WC, Edwards JR. Early biomarkers of cadmium exposure and nephrotoxicity. Biometals. 2010;23:793-809.10.1007/s10534-010-9288-2Open DOISearch in Google Scholar

14. Chen J, Li M, Lv Q, Chen G, Li Y, Li S, Mo Y, Ou S, Yuan Z, Huang M, Jiang Y. Blood lead level and its relationship to essential elements in preschool children from Nanning, China. J. Trace Elem. Med. Biol. 2015;30:137–141.Search in Google Scholar

15. Jan AT, Azam M, Siddiqui K, Ali A, Choi I, Haq QM. Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants. Int J Mol Sci. 2015;16:29592–29630.10.3390/ijms161226183Search in Google Scholar

16. Szablewski L. Distribution of glucose transporters in renal diseases. J Biomed Sci. 2017;24:64.10.1186/s12929-017-0371-7Search in Google Scholar

17. Kataria A, Trasande L, Trachtman H. The effects of environmental chemicals on renal function. Nat Rev Nephrol. 2015;11:610–25.10.1038/nrneph.2015.94Search in Google Scholar

18. Gheith O, Farouk N, Nampoory N, Halim MA, Al-Otaibi T. Diabetic kidney disease: world wide difference of prevalence and risk factors. J Nephropharmacol. 2015;5:49–56.Search in Google Scholar

19. J. Jameson and L. Loscalzo, Harrison’s Nephrology and Acid-Base Disorders, New York: McGraw-Hill Medical, 2017.Search in Google Scholar

20. Persson F, Rossing P. Diagnosis of diabetic kidney disease: state of the art and future perspective. Kidney Int Suppl 2011;8:2-7.10.1016/j.kisu.2017.10.003Search in Google Scholar

21. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982;1:1430–2.10.1016/S0140-6736(82)92450-3Search in Google Scholar

22. Bosman DR, Winkler AS, Marsden JT, Macdougall IC, Watkins PJ. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care 2001;24:495-9.10.2337/diacare.24.3.49511289474Open DOISearch in Google Scholar

23. Chokhandre MK, Mahmoud MI, Hakami T, Jafer M, Inamdar AS. Vitamin D & its analogues in type 2 diabetic nephropathy: a systematic review. J Diabetes Metab Disord. 2015;14:58.10.1186/s40200-015-0186-6450252926180775Search in Google Scholar

24. Lee SY, Choi ME. Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.Pediatr Nephrol.2015;30:1063–75.10.1007/s00467-014-2888-2430549525060761Search in Google Scholar

25. American Diabetes Association. Diabetes and Employment. Diabetes Care. 2010;33 (Suppl1): S82-S86.10.2337/dc10-S082279737920042778Search in Google Scholar

26. American Diabetes Association. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2019. Diabetes Care 2019 42(Suppl 1): S34-S45. https://care.diabetesjournals.org/content/42/Supplement_1/S410.2337/dc19-S00430559230Search in Google Scholar

27. He F, Xia X, Wu XF, Yu XQ, Huang FX. Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis. Diabetologia 2013;56:457–66.10.1007/s00125-012-2796-623232641Open DOISearch in Google Scholar

28. Uwaezuoke SN.The role of novel biomarkers in predicting diabetic nephropathy: a review. Int J Nephrol Renovasc Dis 2017:10: 221-31.10.2147/IJNRD.S143186556636728860837Search in Google Scholar

29. Li Y, Xia W, Zhao F, Wen Z, Zhang A, Huang S, Jia Z, Zhang Y. Prostaglandins in the pathogenesis of kidney diseases. Oncotarget. 2018;9:26586–26602.10.18632/oncotarget.25005599517529899878Search in Google Scholar

30. Al-Rubeaan K, Siddiqui K, Al-Ghonaim MA, Youssef AM, Al-Sharqawi AH, AlNaqeb D. Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients. Sci Rep. 2017;7:2684.10.1038/s41598-017-02421-9545739928577020Search in Google Scholar

31. Kazumi T, Hozumi T, Ishida Y, Ikeda Y, Kishi K, Hayakawa M, Yoshino G.Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes. Diabetes Care. 1999;22:1176-80.10.2337/diacare.22.7.117610388985Search in Google Scholar

32. Montero RM, Herath A, Qureshi A, Esfandiari E, Pusey CD, Frankel AH, Tam FWK. Defining Phenotypes in Diabetic Nephropathy: a novel approach using a cross-sectional analysis of a single centre cohort. Sci Rep. 2018;8:53.10.1038/s41598-017-18595-1575870629311660Search in Google Scholar

33. Qaseem A, Wilt TJ, Kansagara D, Horwitch C, Barry MJ, Forciea MA, Clinical Guidelines Committee of the American College of Physicians. Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: a guidance statement update from the American College of Physicians. Ann Intern Med 2018; 168: 569-76.10.7326/M17-093929507945Search in Google Scholar

34. Weijman I, Ros WJ, Rutten GE, Schaufeli WB, Schabracq MJ, Winnubst JA. Fatigue in employees with diabetes: its relation with work characteristics and diabetes related burden. Occup Environ Med. 2003;60 Suppl 1:i93–i98.10.1136/oem.60.suppl_1.i93176571912782754Search in Google Scholar

35. Umanath K, Lewis JB. Update on Diabetic Nephropathy: Core Curriculum. Am J Kidney Dis. 2018; 71: 884-95.10.1053/j.ajkd.2017.10.02629398179Search in Google Scholar

36. Detaille SI, Haafkens JA, Hoekstra JB, van Dijk FJH. What employees with diabetes mellitus need to cope at work: Views of employees and health professionals. Patient Education andSearch in Google Scholar